202 related articles for article (PubMed ID: 15663651)
1. Lesional T-cell subset in post-kala-azar dermal leishmaniasis.
Rathi SK; Pandhi RK; Chopra P; Khanna N
Int J Dermatol; 2005 Jan; 44(1):12-3. PubMed ID: 15663651
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis.
Ganguly S; Das NK; Panja M; Pal S; Modak D; Rahaman M; Mallik S; Guha SK; Pramanik N; Goswami R; Barbhuiya JN; Saha B; Chatterjee M
J Infect Dis; 2008 Jun; 197(12):1762-71. PubMed ID: 18444882
[TBL] [Abstract][Full Text] [Related]
3. Interferon (IFN)-gamma , tumor necrosis factor-alpha , interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis.
Ansari NA; Ramesh V; Salotra P
J Infect Dis; 2006 Oct; 194(7):958-65. PubMed ID: 16960784
[TBL] [Abstract][Full Text] [Related]
4. Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile.
Ismail A; El Hassan AM; Kemp K; Gasim S; Kadaru AE; Moller T; Kharazmi A; Theander TG
J Pathol; 1999 Dec; 189(4):615-22. PubMed ID: 10629566
[TBL] [Abstract][Full Text] [Related]
5. Post kala azar dermal leishmaniasis in Sudan.
Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
[TBL] [Abstract][Full Text] [Related]
6. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
Karki P; Koirala S; Parija SC; Sethi M; Das ML
Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
[TBL] [Abstract][Full Text] [Related]
7. Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh.
Rahman KM; Islam S; Rahman MW; Kenah E; Ghalib CM; Zahid MM; Maguire J; Rahman M; Haque R; Luby SP; Bern C
Clin Infect Dis; 2010 Jan; 50(1):73-6. PubMed ID: 19951168
[TBL] [Abstract][Full Text] [Related]
8. Post-kala-azar dermal leishmaniasis--an overview.
Ganguly S; Das NK; Barbhuiya JN; Chatterjee M
Int J Dermatol; 2010 Aug; 49(8):921-31. PubMed ID: 21128917
[TBL] [Abstract][Full Text] [Related]
9. In-situ immune profile of polymorphic vs. macular Indian Post Kala-azar dermal leishmaniasis.
Sengupta R; Mukherjee S; Moulik S; Mitra S; Chaudhuri SJ; Das NK; Chatterjee U; Chatterjee M
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():166-176. PubMed ID: 31542359
[TBL] [Abstract][Full Text] [Related]
10. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.
Kaushal H; Bras-Gonçalves R; Avishek K; Kumar Deep D; Petitdidier E; Lemesre JL; Papierok G; Kumar S; Ramesh V; Salotra P
Clin Exp Immunol; 2016 Jul; 185(1):50-60. PubMed ID: 26948150
[TBL] [Abstract][Full Text] [Related]
12. Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.
Karki P; Koirala S; Parija SC; Sethi M; Das ML
Indian J Pathol Microbiol; 2003 Apr; 46(2):214-5. PubMed ID: 15022913
[TBL] [Abstract][Full Text] [Related]
13. Subpopulations of T lymphocytes in the peripheral blood, dermal lesions and lymph nodes of post kala-azar dermal leishmaniasis patients.
Ghosh MK; Nandy A; Addy M; Maitra TK; Ghose AC
Scand J Immunol; 1995 Jan; 41(1):11-7. PubMed ID: 7824884
[TBL] [Abstract][Full Text] [Related]
14. Post-kala-azar dermal leishmaniasis (PKDL), HIV and pulmonary tuberculosis.
Das VN; Pandey K; Verma N; Bimal S; Lal CS; Singh D; Das P
Natl Med J India; 2010; 23(2):88-9. PubMed ID: 20925205
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis.
Mukhopadhyay D; Das NK; De Sarkar S; Manna A; Ganguly DN; Barbhuiya JN; Maitra AK; Hazra A; Chatterjee M
Trans R Soc Trop Med Hyg; 2012 Nov; 106(11):668-76. PubMed ID: 22920931
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of Leishmania parasites in skin lesions of Indian post kala-azar dermal leishmaniasis (PKDL) cases.
Sharma MC; Gupta AK; Verma N; Das VN; Saran R; Kar SK
J Commun Dis; 2000 Mar; 32(1):67-8. PubMed ID: 11129569
[No Abstract] [Full Text] [Related]
17. Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis.
Ganguly S; Mukhopadhyay D; Das NK; Chaduvula M; Sadhu S; Chatterjee U; Rahman M; Goswami RP; Guha SK; Modak D; Mallik S; Gonju D; Pramanik N; Barbhuiya JN; Saha B; Chatterjee M
J Invest Dermatol; 2010 Apr; 130(4):1013-22. PubMed ID: 20032994
[TBL] [Abstract][Full Text] [Related]
18. Pathology of post-kala-azar dermal leishmaniasis: a light microscopical, immunohistochemical, and ultrastructural study of skin lesions and draining lymph nodes.
Ismail A; Gadir AF; Theander TG; Kharazmi A; El Hassan AM
J Cutan Pathol; 2006 Dec; 33(12):778-87. PubMed ID: 17177937
[TBL] [Abstract][Full Text] [Related]
19. The pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: does ultraviolet light (UVB) radiation play a role?
Ismail A; Khalil EA; Musa AM; El Hassan IM; Ibrahim ME; Theander TG; El Hassan AM
Med Hypotheses; 2006; 66(5):993-9. PubMed ID: 16386855
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh.
Islam S; Kenah E; Bhuiyan MA; Rahman KM; Goodhew B; Ghalib CM; Zahid MM; Ozaki M; Rahman MW; Haque R; Luby SP; Maguire JH; Martin D; Bern C
Am J Trop Med Hyg; 2013 Aug; 89(2):345-53. PubMed ID: 23817330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]